“Food and Drug Administration” on The Daily Caller

You can’t blame Americans for feeling as though the government is increasingly crossing boundaries and reaching into their daily lives. The Obama administration and regulatory authorities such as the Environmental Protection Agency (EPA) appear to be coming at us on all fronts. (more)

After staunchly defending the safety of artificial food colorings, the federal government is for the first time publicly reassessing whether foods like Jell-O, Lucky Charms cereal and Minute Maid Lemonade should carry warnings that the bright artificial colorings in them worsen behavior problems like hyperactivity in some children. (more)

Forget comedy clubs, if you really want a laugh these days you simply have to venture over to the Media Matters website. The extent to which the organization is willing to contort reality to keep fellow “progressives” in line is nothing short of an expert yoga class. Given their recent “declaration of war” against Fox News for perceived bias, and the questionable legality of it given the group’s “charity” tax status, this is as surprising as the sun rising in the east each morning. There is no length to which Media Matters’ employees will not go to defend anything Democrats do; it’s what they’re paid to do. So it came as little surprise that on the one-year anniversary of Obamacare’s passage, Media Matters was there to defend the unpopular law. (more)

Last year, not long after the Food and Drug Administration got legislative authority to regulate tobacco, “flavored” cigarettes were banned — on behalf of the children. (more)

A potential ban on menthol cigarettes has sparked a debate within the African American community over whether a government ban should be welcomed for health reasons or considered a condescending demonstration of paternalism. (more)

In late January, Obama administration officials announced that they were very concerned about the slow pace of new drugs coming from the pharmaceutical industry. They should be concerned. The number of new chemical entities (NCEs) launched in recent years is near historic lows. And there are many unmet medical needs for which no therapies are available or on the horizon. (more)

For decades, the United States has been the world leader in medical innovation. Individuals come from around the world to receive the best and latest care. What was experimental just a few years ago becomes common medical practice, saving and improving American lives. (more)

If it wasn’t so sad, it would be funny. The brain trust at the Consumers Union doesn’t seem to be able to see the consequences of their actions. (more)

The National Institutes of Health recently announced that it would be engaging in a billion-dollar effort to encourage the development of new pharmaceutical therapies. The New York Times headline for this story sounded innocuous: “Federal Research Center Will Help Develop Medicines.” But not everyone is so sanguine about this effort. Fox News, for example, re-ran the Times story under the header: “Obama Creating Billion Dollar Gov’t-Run Drug Company.” (more)

They’ve already dished up python, alligator, elk, kangaroo, rattlesnake, and turtle. (more)

To say the government regulates everything is an understatement. Aside from the black market, which is only unregulated insofar as it avoids taxes and bypasses age restrictions on such things as alcohol (not including illegal products), there really isn’t much in which the government doesn’t have a hand. And now they’re thinking about coming after your hand…well, your hand soap, anyway. (more)

The U.S. Food and Drug Administration says makers of combination prescription medications can include no more than 325 mg of acetaminophen in each tablet or capsule. (more)

Here’s a word of advice to the Food and Drug Administration (FDA) regulators deciding this week whether or not to ban menthol cigarettes: Cool it. If the FDA sows this wind, I fear we will reap the whirlwind. (more)

On Tuesday, President Obama signed one of the most expansive food regulation bills in living memory, giving the Food and Drug Administration sweeping regulation powers over food production and distribution. (more)

This New Years Eve, while you’re chugging Four Loko and lobbing Happy Meal toys at one another, poised to inaugurate a new Congress and partying like it’s 2012, beware of that hog in the corner. He’s a big-government bureaucrat and he’s come to crash the bash. The newly elected Republican majority’s campaign promises of smaller government and less intrusion into Americans’ lives are reasons to celebrate, but the Obama administration’s unilateral, over-regulating agenda is barreling uninvited into the party. (more)

(CBS) In this exclusive story, CBS News chief investigative correspondent Armen Keteyian reports the latest terror attack to America involves the possible use of poisons – simultaneous attacks targeting hotels and restaurants at many locations over a single weekend. (more)

The Food and Drug Administration said on Thursday that it would move to revoke approval of the widely used drug Avastin as a treatment for breast cancer, saying the drug was not effective in helping patients. (more)

OnFriday, the Food and Drug Administration could doom thousands of breast cancer victims. The FDA will be considering the unprecedented step of revoking approval for Avastin, a drug that represents the last hope for women with late-stage breast cancer. About 17,500 women a year are treated with the drug, which cuts off blood flow to tumors. It does not cure cancer, but it does stop its growth and extend life. Unfortunately, medical miracles don’t come cheap — treating a breast cancer patient with Avastin can cost $90,000 a year. In 2008, the FDA’s Oncologic Drugs Advisory Committee put Avastin on a track to “accelerated approval” following a clinical study showing 52 percent of the women on the drug showed improvement in “progression-free survival.” On average, Avastin extended the life of patients by 5 1/2 months, but some survive for years. Subsequent clinical studies showed only 36 percent and 31 percent of women had improved survival rates, a far better outcome than the alternative — death. The FDA confirmed last year that Avastin would be approved pending “improvement in progression-free survival and evidence that survival is not impaired.” (more)

Four and a half years ago, my mom was diagnosed with Stage II breast cancer. (more)